Physician profile
Patrick John Sanchez
NPI 1578975421
$4,670.14
in general payments reported to CMS, 2019-2025
14 companies · $993 in 2025
The $993 reported for 2025 was more than what 80% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $253 · 2021: $40.16 · 2022: $953 · 2023: $935 · 2024: $534 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,457.02 | 2020-2025 | Augment Injectable, Ortholoc 3di, Ortholoc 2 Lapifuse |
| Kerecis Limited | $561.26 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medwest Associates | $385.00 | 2019 | |
| Acera Surgical, INC. | $270.79 | 2021-2022 | |
| Wright Medical Technology, INC. | $259.96 | 2019-2020 | |
| Depuy Synthes Sales INC. | $223.73 | 2019-2025 | Motoband |
| Organogenesis INC. | $189.82 | 2019-2025 | Apligraf |
| Integra Lifesciences Corporation | $131.99 | 2019 | |
| Orthofix Medical, INC. | $63.14 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $52.92 | 2019-2020 | |
| Acell, INC. | $22.01 | 2019 | |
| Mimedx Group, INC. | $20.19 | 2025 | |
| Lightbody Medical Technologies INC | $17.99 | 2025 | |
| Kci USA, INC. | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.